<\/p>\n
Baton Rouge, Louisiana, Jul 10, 2025 – Hospital Services \u2013 Coverage of Gene Therapies for Sickle Cell Disease\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LAC 50:V.120<\/strong><\/p>\n
<\/p>\n Continues the July 1, 2025 Emergency Rule which adopted cell and gene therapy model that provides additional supplemental and federal rebates for gene therapies for sickle cell disease.<\/p>\n
<\/p>\n Contact Information: Kimberly Sullivan, Bureau of Health Services Financing, P.O. Box 91030, Baton Rouge, LA 70821-9030<\/p>\n
<\/p>\n Disclaimer:\u00a0 Please note that the official versions of the Notices of Intent are maintained by the Office of State Register\u2019s website at http:\/\/www.doa.louisiana.gov\/osr\/osr.htm. \u00a0The excerpted versions of these Notices of Intent contained on this website are provided as a courtesy service to the public and is unofficial and should not be regarded as such.\u00a0Users are encouraged to visit the Office of State Register\u2019s website for the official version.<\/p>\n
<\/p>\n Emergency Rule<\/strong><\/p>\n
<\/p>\n July 1, 2025<\/p>\n
<\/p>\n Notice of Intent<\/strong><\/p>\n
<\/p>\n Prior to Proposed Rule:\u00a0 N\/A<\/p>\n
<\/p>\n